This month, Jiahui Health and The Estée Lauder Companies Inc. established a joint clinical research center focused on transforming post-aesthetic procedure skincare and holistic patient recovery.

China currently leads the world in post-procedure care market size, with consumers increasingly demanding scientifically-backed, safe, and effective recovery solutions.

The partnership perfectly combines Estée Lauder's advanced scientific research with Jiahui Health's clinical experience in aesthetic medicine, leveraging deep consumer insights and industry trends to foster resource sharing and collaboration. Key focus areas include clinical research, advanced product development, and consumer insights.

 

Attendees at the Signing Ceremony
Dr. Allen Wu, President of Jiahui Health
Ms. Hongyan Guan, Trustbridge Partner & Jiahui Health Corporate Leader
Dr. Michelle Ding, Executive Director of Cosmetic Center and Chief of Dermatology at Jiahui Health
Dr. Justin He, Vice President, R&D China & APAC at The Estée Lauder Companies
Dr. Yan Zhong, Senior Director, Clinical and Claims, R&D China & APAC at The Estée Lauder Companies
Ms. Rachel Zhao, Clinical R&D Associate Director

Dr. Allen Wu emphasized the potential of this collaboration: "We look forward to deeper research interactions that will provide more possibilities for individuals seeking aesthetic improvements."

"As the post-aesthetic care market continues to grow significantly," says Dr. Justin He, Vice President, R&D China & APAC at The Estée Lauder Companies, "We're excited to partner with Jiahui Health to capture local trends and professional insights. Our goal is to bring transformative skincare solutions to consumers in China and globally."